GlassScriptPhysician profile
Daniel A Katzman
NPI 1326090051
$332.98
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2023: $31.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $31.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $31.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Auris Health, INC. | $209.64 | 2019 | |
| Medline Industries LP | $31.37 | 2023 | |
| Genentech USA, INC. | $22.21 | 2019 | |
| Janssen Pharmaceuticals, INC | $20.54 | 2019 | |
| Chiesi USA, INC. | $17.14 | 2019 | |
| Allergan, INC. | $16.36 | 2019 | |
| Mylan Specialty L.P. | $15.72 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Katzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.